Zobrazeno 1 - 10 of 10 pro vyhledávání: '"E N, Iushchuk"'
1
[Renin inhibitors--new direction in the treatment of arterial hypertension]
Autor: Iu A, Vasiuk, I A, Sadulaeva, E N, Iushchuk, O S, Trofimenko, M V, Chirkov, V S, Fedoseeva, K G, Kulikov
Publikováno v: Terapevticheskii arkhiv. 82(9)
The paper covers current problems in the treatment of arterial hypertension. Renin is an important and promising therapeutic target. The direct renin inhibitor aliskiren (Rasilez) is a promising current effective antihypertensive agent that has cardi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8c32c7a010519aa391c8c8e937d479a7
https://pubmed.ncbi.nlm.nih.gov/21086622
Zobrazit plný text záznamu
3
[Receptor regulation of the platelet activity]
Autor: A G, Muliar, M T, Gasanov, E N, Iushchuk, O V, Dunaeva, Iu S, Avfukova
Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia. 67(1)
Classification of thrombocyte receptors is given, their functions are discussed, and their endogenous and exogenous ligands are considered as potential targets for antithrombotic drugs.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c550a10a6b0670ed1e4b5ada7c37340
https://pubmed.ncbi.nlm.nih.gov/15079913
Zobrazit plný text záznamu
7
[The effect of the tempi of rehabilitation on the psychological status and quality of life in myocardial infarct patients]
Autor: A B, Khadzegova, T A, Aĭvazian, V P, Pomerantsev, Iu A, Vasiuk, A A, Gabrielian, E N, Iushchuk
Publikováno v: Terapevticheskii arkhiv. 69(11)
104 patients 3 to 12 months after myocardial infarction were evaluated psychologically and by quality of life. Faster hospital rehabilitation contributed to better quality of life than in patients on conventional rehabilitation. The absence of sanato
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da59a616c37154d788bb47380d193821
https://pubmed.ncbi.nlm.nih.gov/9483752
Zobrazit plný text záznamu
8
[Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure]
Autor: Iu A, Vasiuk, E N, Iushchuk, E L, Shkol'nik, A B, Khadzegova, N K, Vit'ko, M N, Vakhromeeva
Publikováno v: Europe PubMed Central
Efficacy of metabolic therapy with trimetazidine MR and 3-(2,2,2-trimethylhydrazyn) propionatodihydratum (3-TMHP) was compared in patients with chronic heart failure (CHF) of ischemic genesis. Clinico-functional examination included dobutamine stress
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::86a59b188ff38d5deab0b4a2311a1fce
http://europepmc.org/abstract/med/17159882
Zobrazit plný text záznamu
9
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure]
Autor: Iu A, Vasiuk, E N, Iushchuk, E L, Shkol'nik, A B, Khadzegova, I A, Sadulaeva, N K, Vit'ko, M N, Vakhromeeva
Publikováno v: Europe PubMed Central
To study efficacy of the myocardial cytoprotector trimethasidine MB and metabolic drug 3-(2,2,2-trimethylhydrasine) propionate dihydrate (3-TMHP) in the treatment of chronic cardiac failure (CCF).Sixty-five patients with CCF after myocardial infarcti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::45a51fc3ffb1d73a19d8dad09d4f4be0
http://europepmc.org/abstract/med/17460970
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje